- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01136629
Clinical, Histological and Biochemical Characterization of Hyperpigmented Lesion
Clinical, Histological and Biochemical Characterization of Hyperpigmented Lesion.
Hypothesis -
The developments of solar lentigine and melasma are due to mutations in keratinocytes that drive the production and transfer of pigment from melanocytes to keratinocytes.
Study Overview
Detailed Description
Aims -
- Characterize and classify lentigines and mealsma from a clinical and physiological point of view. This will help us to better understand the cellular processes leading to the development of lentigines (also referred to as Senile or Solar Lentigo).
- Proper characterization and classification of lentigines and melasma would facilitate the development of models to study and find solutions to treat these lesions.
Hypothesis - The developments of solar lentigine and melasma are due to mutations in keratinocytes that drive the production and transfer of pigment from melanocytes to keratinocytes.
Methodology -
Patients, 21 - 80 year old, who have elected to undergo a plastic surgery will be enrolled. Some patient information (i.e. age, sex, race, family history, life-style related to sun-exposure) will be collected.
After surgery, hyper-pigmented spots will be excised and stored in individual containers for subsequent experimental procedures.
Before surgery, the area containing the hyper-pigmented spots will be photographed using a high resolution digital camera and assessed using optical probes (Spectrophotometer to measure skin chromophores, mexameter to measure the melanin and erythema indexes and a diffuse reflectance spectrometer to measure hemoglobin, deoxyhemoglobin and melanin).
After surgery, excised skin samples will be processed for histological assessments, others for gene or protein expression analysis, and yet another group will be used to isolate keratinocyte and melanocyte to further study their behavior and response to stimuli in primary cultures.
Clinical assessment of Hyperpigmented lesions:
Lentigo Morphological assessment (before surgery)
- Macules vary in color from yellow, light-brown to black, depending on under-lying skin type
- Size varies from 1mm to greater than 1 cm
- Appear on sun-exposed areas (face, neck, etc)
Morphological assessment (before surgery)
- Irregular light to dark brown to gray brown macules or patches on sun-exposed areas
- When examine with Wood's lamp, melasma can be classified into 3 types, epidermal, dermal, or mixed, based on intensity of pigments, in which epidermal melasma has darker color than derma melasma. Mixed melasma has a mixture of both dark and light pigmentations
- Melanocytes in melasma lesion have an increase in the number of mitochondria, golgi apparatus, rough ER, and ribosomes
Spectrophotometer will be used to measure the optical properties of spots and control areas (without the spot)
Sample processing
- RNA extraction
- Histology
- Isolation of Keratinocytes, and Melanocytes.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Locations
-
-
-
Singapore, Singapore, 119074
- Recruiting
- National University Hospital, Singapore
-
Contact:
- Thiam Chye Lim, MD
- Phone Number: 65-67722022
- Email: surlimtc@nus.edu.sg
-
Contact:
- Eileen Hing
- Phone Number: 65-67722276
- Email: surhch@nus.edu.sg
-
Principal Investigator:
- Thiam Chye Lim, MD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Solar Lentigines and/or Melasma on facial, or neck areas
- Ethnic background: Chinese, Malay, Indian, Caucasian
- Age 21 - 80 years old
- Ability to provide informed consent
Exclusion Criteria:
- Pregnant and lactating women
- Children under the age of 20
- Neoplasm (past or present) in excised area
- Patients with communicable disease
- Immuno-compromised patients
- Current treatment with an investigational drug
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Subjects with hyper-pigmented spots
Subjects age 21 to 80 year old, who have elected to undergo a plastic surgery will be enrolled.
Subjects will be from Chinese, Malay, Indian or Caucasian ancestry.
Subjects will be female or male with a hyper-pigmented spots.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Characterization and classification of lentigines and melasma
Time Frame: 3 years
|
Characterize and classify lentigines and mealsma from a clinical and physiological point of view. This will better understand the cellular processes leading to the development of lentigines (also referred to as Senile or Solar Lentigo). Proper characterization and classification of lentigines and melasma would facilitate the development of models to study and find solutions to treat these lesions. |
3 years
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- NUHS/SUR-PRAS/2010/4
- D / 08 / 175 (REGISTRY: DSRB - D / 08 / 175)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Melasma
-
Foundation University IslamabadFauji Foundation HospitalNot yet recruitingMelasma | Melasma (Facial Melasma)Pakistan
-
Gujranwala medical college District Headquarters...CompletedMelasma | Melasma (Facial Melasma)Pakistan
-
Venus Research CenterEnrolling by invitationMelasma | Melasma (Facial Melasma)Egypt
-
Laboratoire Dermatologique ACMCIDP MauritiusRecruitingHealthy | Melasma (Facial Melasma) | Epidermal MelasmaMauritius
-
Pak Emirates Military HospitalCompletedMelasma (Facial Melasma)Pakistan
-
Hina MalikEnrolling by invitationMelasma (Facial Melasma)Pakistan
-
Kasr El Aini HospitalRecruitingMelasma | Facial MelasmaEgypt
-
The First Affiliated Hospital with Nanjing Medical...Recruiting
-
EgymedicalpediaAswan UniversityRecruiting
-
Mesoestetic Pharma Group S.L.Completed